JACC: Heavy Metals, Cardiovascular Disease, and the Unexpected Benefits of Chelation Therapy
Wednesday, May 18, 2016
Posted by: Administration
This review summarizes evidence from 2 lines of research previously thought to be unrelated: the unexpectedly positive results of TACT (Trial to Assess Chelation Therapy), and a body of epidemiological data showing that accumulation of biologically active metals, such as lead and cadmium, is an important risk factor for cardiovascular disease. Considering these 2 areas of work together may lead to the identification of new, modifiable risk factors for atherosclerotic cardiovascular disease. We examine the history of chelation up through the report of TACT. We then describe work connecting highermetal levels in the body with the future risk of cardiovascular disease. We conclude by presenting a brief overview of
a newly planned National Institutes of Health trial, TACT2, in which we will attempt to replicate the findings of TACT and to establish that removal of toxic metal stores from the body is a plausible mechanistic explanation for the benefits of edetate disodium treatment. (J Am Coll Cardiol 2016;67:2411–8) © 2016 by the American College of Cardiology Foundation.
READ COMPLETE ARTICLE